HHS “Unified Agenda” Shows FDA Is Behind On OTC Actions
This article was originally published in The Pink Sheet Daily
Executive Summary
More than half of OTC drug and dietary supplement action items in the FDA regulatory agenda are holdovers from the first half of the year. FDA intends to complete 15 OTC-related actions in the second half of the year.